Skip to main content
MENS logo

Jyong Biotech Ltd.

MENSNASDAQHealthcareBiotechnology

$1.84Today:- (-)1Y −96.64%

As of Oct 16, 2026 close

Market cap
$144.56M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.43$63.00
Volume (live)
-
Avg. volume (3M)
48.04K

Jyong Biotech (MENS) Stock Price & Financial Analysis

Jyong Biotech Stock Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Price & Trading Activity
Day's Range$1.80 - $2.02
52-Week High$63.00
52-Week Low$1.43
Open$1.97
Volume (last close)41.17K
Average Volume (3M)48.04K
Technical Indicators
50-Day MA$2.12
200-Day MA$2.26
1-Year Change−96.64%
Size & Valuation
Market Cap144.56M
Shares Outstanding73.01M
Price to Book (P/B)-5.80
EV/EBITDA-64.59
Dividend Information
Annual Dividend$0.00
Dividend Yield0.00%

Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology

Compare MENS with other stocks

Jyong Biotech at a Glance

As of the Oct 16, 2026 close, Jyong Biotech (MENS) has a market capitalization of $144.56M.

As of its latest reported balance sheet, it holds $1.18M in cash and securities against $18.55M of debt, a net debt position of $17.37M.

Jyong Biotech does not currently pay a dividend.

The share price is down 96.6% over the past year. At $1.84 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $1.43 to $63.00, below its 200-day moving average of $2.26.

Frequently Asked Questions About Jyong Biotech

What is the current stock price for MENS?

As of the Oct 16, 2026 close, MENS stock trades at $1.84. The 52-week range is $1.43–$63.00, with a day range of $1.79–$2.02.

What is the P/E ratio for MENS?

The P/E ratio (Price-to-Earnings) for MENS is shown in the Key Statistics section. This valuation metric helps compare Jyong Biotech Ltd. to industry peers.

Does MENS pay dividends?

Jyong Biotech does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.

What do analysts recommend for MENS?

Analyst ratings and recommendations for MENS are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of MENS?

As of the Oct 16, 2026 close, Jyong Biotech's market capitalization is $134.3M, classifying it as a micro-cap company. Jyong Biotech operates in the Healthcare sector within the Biotechnology industry.